Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
35
PET Quote, Financials, Valuation and Earnings
Last price:
$0.15
Seasonality move
:
-13.02%
Day range:
$0.14 - $0.16
52-week range:
$0.08 - $2.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.09x
P/B ratio:
4.11x
Volume:
3M
Avg. volume:
7.3M
1-year change:
-93.58%
Market cap:
$7.4M
Revenue:
$70.5M
EPS (TTM):
-$0.40
Analysts' Opinion
-
Consensus RatingWag Group has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Wag Group has an estimated upside of 243.64% from its current price of $0.15.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $0.15.
Fair Value
-
According to the consensus of 1 analyst, Wag Group has 243.64% upside to fair value with a price target of -- per share.
PET vs. S&P 500
-
Over the past 5 trading days, Wag Group has overperformed the S&P 500 by 53% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Wag Group does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Wag Group revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Wag Group reported revenues of $15.4M.
Earnings Growth
-
Wag Group has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Wag Group reported earnings per share of -$0.10.
Enterprise value:
20.7M
EV / Invested capital:
--
Price / LTM sales:
0.09x
EV / EBIT:
--
EV / Revenue:
0.29x
PEG ratio (5yr expected):
-0.03x
EV / Free cash flow:
-2.34x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$65.2M
Return On Assets:
-47.97%
Net Income Margin (TTM):
-24.92%
Return On Equity:
-17257.37%
Return On Invested Capital:
-77.88%
Operating Margin:
-22.93%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $54.9M | $83.9M | $70.5M | $21.7M | $15.4M | |
| Gross Profit | $50.8M | $76.6M | $65.2M | $19.9M | $14M | |
| Operating Income | -$31.1M | -$7.2M | -$10.4M | -$1.9M | -$3.5M | |
| EBITDA | -$35.1M | -$4.7M | -$8.8M | -$1.2M | -$2.9M | |
| Diluted EPS | -$1.69 | -$0.35 | -$0.40 | -$0.09 | -$0.10 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $12M | $47.4M | $31.8M | $15.1M | |
| Total Assets | -- | $16.5M | $52.3M | $46.7M | $29.4M | |
| Current Liabilities | -- | $10M | $16.5M | $18.4M | $29.5M | |
| Total Liabilities | -- | $122.6M | $42.4M | $45.1M | $29.9M | |
| Total Equity | -- | -$106.1M | $9.9M | $1.6M | -$489K | |
| Total Debt | -- | $1.6M | $26.2M | $27.4M | $19M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$2.8M | -$6.5M | -$7M | -$1.8M | -$1.7M | |
| Cash From Investing | $1.8M | -$12.3M | -$2M | -$1.6M | -$567K | |
| Cash From Financing | $37.1M | -$1.9M | -$3.7M | -$541K | -$519K | |
| Free Cash Flow | -$2.9M | -$6.8M | -$8.8M | -$2.2M | -$2.3M | |
PET
Sector
Market Cap
$7.4M
$401M
Price % of 52-Week High
5.89%
66.47%
Dividend Yield
0%
0%
Shareholder Yield
--
3.88%
1-Year Price Total Return
-93.58%
-17.67%
Beta (5-Year)
--
0.832
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.13
200-day SMA
Sell
Level
$0.53
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$0.13
Relative Strength Index (RSI14)
Sell
Level
48.35
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-37.6106
50-day SMA
Sell
Level
$0.20
MACD (12, 26)
Sell
Level
-0.02
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-7.7333)
Sell
CA Score
(Annual)
Level (-3.288)
Sell
Beneish M-Score
(Annual)
Level (-1.5246)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (7.9484)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent’s home, advice from licensed pet experts, training services, pet insurance comparison tools and pet wellness plans.
Stock Forecast FAQ
In the current month, PET has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The PET average analyst price target in the past 3 months is --.
-
Where Will Wag Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that Wag Group share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Wag Group?
Analysts are divided on their view about Wag Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Wag Group is a Sell and believe this share price will drop from its current level to --.
-
What Is Wag Group's Price Target?
The price target for Wag Group over the next 1-year time period is forecast to be -- according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is PET A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Wag Group is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of PET?
You can purchase shares of Wag Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Wag Group shares.
-
What Is The Wag Group Share Price Today?
Wag Group was last trading at $0.15 per share. This represents the most recent stock quote for Wag Group. Yesterday, Wag Group closed at $0.15 per share.
-
How To Buy Wag Group Stock Online?
In order to purchase Wag Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for May 1
Hims & Hers Health [HIMS] is down 5.48% over the past day.
Buy
53
EAT alert for May 1
Brinker International [EAT] is down 1.82% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 3.3% over the past day.
